IRCT20190912044756N1
Completed
Phase 3
Evaluation of efficacy of intra articular injection of mannitol versus hypertonic dextrose prolotherapy on decreasing pain and improvement of functions in patients with knee osteoarthritis
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Osteoarthritis of knee.
- Sponsor
- Shiraz University of Medical Sciences
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age: 38 to70 years old
- •Gender: male or female
- •Knee radiography anterior standing view have been for the last three month
- •Have symptoms of osteoartritis include pain, crepitation for at least a month without any extra articular involvment
Exclusion Criteria
- •Any injection of the knee joint during the last three of months
- •sensitivity reaction to test drug
- •The patient have done total knee arthroplasty
- •The patient have diseases mimicking the symptoms of knee pain such as neuropathy and radiculopathy
- •Diseases such as rheumatoid arthritis, Reiter's syndrom, gout
- •Uncontrolled diabetes,HBA1c more than7\.5, BMI more than 40
- •History of knee trauma,fracture
- •Patient's mental disorder
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
The effectiveness of Hyaluronic acid/Chondroitin injection on knee performance after surgical fixation.IRCT20170608034390N13Shahid Beheshti University of Medical Sciences32
Completed
Phase 2
Assessing the Efficacy of Intra-articular Injection of High Molecular Weight Hyaluronic Acid on Knee Function of Patients with Tibial Plateau Fracture after Surgical FixatioIRCT20170608034390N3Shahid Beheshti University of Medical Sciences32
Recruiting
Not Applicable
Eficacy of intra-articular injections for the treatment of frozen shoulderDiseases of the musculo-skeletal system and connective tissueKCT0003105Keimyung University Dongsan Medical Center90
Completed
Not Applicable
The efficacy and safety of intra-articular injections with the tumour-necrotising factor alpha (TNFa) antagonist infliximab in patients with chronic or recurrent arthritis of the kneeArthritis, spondyloarthropathy, rheumatoid arthritisMusculoskeletal DiseasesOther rheumatoid arthritisISRCTN17726268eiden University Medical Centre (LUMC) (The Netherlands)40
Completed
Not Applicable
To evaluate the effect of blood product injected in to the jaw joint for management of jaw disordersHealth Condition 1: null- Patients with temporomandibular joint disorders and refractory to conservative managementCTRI/2018/05/013988Dr kranthi kumar10